Cargando…
Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review
The Coronavirus Disease 2019 (COVID-19) pandemic has resulted in significant morbidity and mortality worldwide. Although initial reports concentrated on severe respiratory illness, emerging literature has indicated a substantially elevated risk of thromboembolic events in patients with COVID-19 dise...
Autores principales: | Cryer, Michael Joseph, Farhan, Serdar, Kaufmann, Christoph C., Jäger, Bernhard, Garg, Aakash, Krishnan, Prakash, Mehran, Roxana, Huber, Kurt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793375/ https://www.ncbi.nlm.nih.gov/pubmed/35068227 http://dx.doi.org/10.1177/10760296221074353 |
Ejemplares similares
-
Editorial: Thrombotic Disorders, Prothrombotic Abnormalities and COVID-19
por: Di Micco, Pierpaolo, et al.
Publicado: (2021) -
Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients
por: Aghamohammadi, Mehdi, et al.
Publicado: (2020) -
Unpuzzling COVID-19 Prothrombotic State: Are Preexisting Thrombophilic Risk Profiles Responsible for Heterogenous Thrombotic Events?
por: Burlacu, Alexandru, et al.
Publicado: (2020) -
Acute Thrombotic Event From Covid-19 Infection: Short-term Follow-up
por: Faries, Christopher M., et al.
Publicado: (2021) -
Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity
por: Clark, Chantal C., et al.
Publicado: (2021)